http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24489646
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
169
issn
0920-1211
issueIdentifier
2
pageRange
166-169
publicationName
Epilepsy Research
startingPage
166
bibliographicCitation
Rentmeester T, Hulsman J. Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients. Epilepsy Res. 1991 Mar;8(2):166–9. doi: 10.1016/0920-1211(91)90085-t. PMID: 2065645.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c7f1368595eefd55c79b10432d94228
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_937489f08f5b02091203be6e7c9cce39
date
199103
identifier
https://pubmed.ncbi.nlm.nih.gov/2065645
https://doi.org/10.1016/0920-1211%2891%2990085-t
isPartOf
https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients
discusses
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0021911
http://id.nlm.nih.gov/mesh/M0182321
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D014230Q000627
http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D000927Q000009
http://id.nlm.nih.gov/mesh/D014230Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D004351
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004827Q000503
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034012
Total number of triples:
38
.